Overview

Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081)

Status:
Completed
Trial end date:
2008-04-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effectiveness of rizatriptan benzoate in the early treatment of an acute migraine attack.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Rizatriptan